SeekingBiotech27分钟前
VTYX Announces Results from the Phase 2 Trial of VTX958 in Participants with Moderately to Severely Active Crohn’s Disease.
- The Phase 2 trial did not meet its primary endpoint of change from baseline in mean CDAI score in either VTX958 dose group
tyk2虽火。但失败...
产业链观察05-03 20:27
#药闻简讯# 第一位NLRP3i(NNC6022-0001,以前称为VENT-01)患者治疗给药。$Ventyx Biosciences(VTYX)$ 宣布首位使用NLRP3抑制剂进行临床研究的参与者,该抑制剂独家授权给诺和诺
Ventyx Biosciences(VTYX)05-18 04:25
$Ventyx Biosciences(VTYX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-013502 Size: 5 KB 网页链接
Ventyx Biosciences(VTYX)06-07 04:15
$Ventyx Biosciences(VTYX)$ 8-K Current report, item 5.07 Accession Number: 0001193125-24-156047 Act: 34 Size: 157 KB 网页链接
Ventyx Biosciences(VTYX)06-27 05:25
$Ventyx Biosciences(VTYX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0000929638-24-002278 Act: 34 Size: 87 KB 网页链接
Ventyx Biosciences(VTYX)06-08 04:35
$Ventyx Biosciences(VTYX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015971 Size: 12 KB 网页链接
Ventyx Biosciences(VTYX)06-08 04:25
$Ventyx Biosciences(VTYX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015967 Size: 5 KB 网页链接
Ventyx Biosciences(VTYX)06-08 04:35
$Ventyx Biosciences(VTYX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015992 Size: 12 KB 网页链接
Ventyx Biosciences(VTYX)05-10 04:15
$Ventyx Biosciences(VTYX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-056914 Act: 34 Size: 250 KB 网页链接
Ventyx Biosciences(VTYX)05-02 04:15
$Ventyx Biosciences(VTYX)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001193125-24-127439 Act: 33 Size: 295 KB 网页链接